Concepedia

Steven J. Lemery

SJ

Statistics

Publications

43

Citations

4.8K

H-Index

29

Active since

2005

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

National Institutes of Health

National Heart Lung and Blood Institute

Steven J. Lemery is an author at Center for Drug Evaluation and Research specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2005–2024

43

Publications

43

FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors

Leigh Marcus, Steven J. Lemery, Patricia Keegan et al. · Clinical Cancer Research · 2019 · 1.2K citations

, , +14

First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication

Steven J. Lemery, Patricia Keegan, Richard Pazdur · New England Journal of Medicine · 2017 · 658 citations

, , +17

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors

Leigh Marcus, Lola A. Fashoyin‐Aje, Martha Donoghue et al. · Clinical Cancer Research · 2021 · 568 citations · Full text

, , +17

Tumor necrosis factor α blockers and malignancy in children: Forty‐eight cases reported to the food and drug administration

Peter Diak, Jeffrey Siegel, Lois La Grenade et al. · Arthritis & Rheumatism · 2010 · 253 citations

, , +15

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2020 · 178 citations

, , +15

1–5 of 43